Charles Schwab Investment Management Inc Eledon Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 29,987 shares of ELDN stock, worth $140,938. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,987
Previous 14,987
100.09%
Holding current value
$140,938
Previous $37,000
229.73%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ELDN
# of Institutions
41Shares Held
18.7MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA6.29MShares$29.6 Million0.5% of portfolio
-
Armistice Capital, LLC New York, NY2.36MShares$11.1 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.57MShares$7.36 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.5MShares$7.05 Million0.03% of portfolio
-
Zimmer Partners, LP New York, NY1.43MShares$6.74 Million0.07% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $64.7M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...